A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Sam, Michelle R ^a,b   Elliott, Bruce E ^a,b   Mueller, Christopher R ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; TYROSINE; STAT3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HELA CELL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TYROSINE;

EID: 37749053058     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-69     Document Type: Article

References (25)

1. Matsumoto K Nakamura T: Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. International Journal of Cancer 2006, 119:477-483. 10.1002/ijc.21808
2. Jiang WG Martin TA Parr C Davies G Matsumoto K Nakamura T: Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Critical Reviews in Oncology/Hematology 2005, 53:35 -69. 10.1016/j.critrevonc.2004.09.004 15607934
3. Peruzzi B Bottaro DP: Targeting the c-Met Signaling Pathway in Cancer. Clin Cancer Res 2006, 12:3657-3660. 10.1158/1078-0432.CCR-06-0818 16778093
4. Maulik G Shrikhande A Kijima T Ma PC Morrison PT Salgia R: Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine & Growth Factor Reviews 2002, 13:41-59. 10.1016/S1359-6101(01)00029-6 11750879
5. Elliott BE Hung W Boag A Tuck A: The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Canadian Journal of Physiology and Pharmacology 2002, 80:91-102. 10.1139/ y02-010
6. Wang Y Selden AC Morgan N Stamp GW Hodgson HJ: Hepatocyte growth factor/ scatter factor expression in human mammary epithelium. American Journal of Pathology 1994, 144:675-682. 1887246 8160769
7. Jin L Fuchs A Schnitt SJ Yao Y Joseph A Lamszus K Park M Goldberg ID Rosen EM; Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer, 1996,79:749-760. 10.1002/ (SICI)1097-0142(19970215)79:4<749::AID-CNCR12<3.0.CO;2-#
8. Beviglia L Matsumoto K Lin C Ziober B Kramer R: Expression of the c-Met/ HGF receptor in human breast carcinoma correlation with tumour progression. International Journal of Cancer 1997, 74:301-309. 10.1002/ (SICI)1097-0215(19970620)74:3<301::AID-IJC12<3.0.CO;2-E
9. Verbeek BS Vroom TM driaansen-Slot SS Ottenhoff-Kalff AE Geertzema JG Hennipman A Rijksen G: C-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 1996, 180:383-388. 10.1002/ (SICI)1096-9896(199612)180:4<383::AID-PATH686<3.0.CO;2-N 9014858
10. Diaz N Minton S Cox D Bowman T Gritsko T Garcia R Eweis I Wlock M Livingston S Seijo E Cantor A Lee J Beam C Sullivan D Jove R Muro-Caco C: Activation of Stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res 2006, 12:20-28. 10.1158/ 1078-0432.CCR-04-1749 16397019
11. Bowman T Garcia R Turkson J Jove R: STATS in oncogenesis. Oncogene 2000, 19:2474-2483. 10.1038/sj.onc.1203527 10851046
12. Frame M; Src in cancer: Deregulation and consequences for cell behaviour. Biochimica et Biophysica Acta 2002, 1602:114-130. 12020799
13. Rahimi N Hung W Tremblay E Saulner R Elliott B: C-Src Kinase Activity Is Required for Hepatocyte Growth Factor-induced Motility and Anchorage-independent Growth of Mammary Carcinoma Cells. J Biol Chem 1998, 273:33714-33721. 10.1074/jbc.273.50.33714 9837958
14. Zhang Y Wang L Jove R Vande Woude G: Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 2002, 21:217-226. 10.1038/ sj.onc.1205004 11803465
15. Avizienyte E Brunton VG Fincham VJ Frame MC: The SRC-induced mesenchymal state in late-stage colon cancer cells. Cells Tissues Organs 2005, 179:73-80. 10.1159/000084511 15942195
16. Gritsko T Williams A Turkson J Kaneko S Bowman T Huang M Nam S Eweis I Diaz N Sullivan D Yoder S Enkemann S Eschrich S Lee JH Beam CA Cheng J Minton S Muro-Cacho CA Jove R: Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006, 12:11-19. 10.1158/ 1078-0432.CCR-04-1752 16397018
17. Turkson J Bowman T Garcia R Caldenhoven E De Groot RP Jove R: Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 1998, 18:2545-2552. 110634 9566874
18. Wojcik EJ Sharifpoor S Miller NA Wright TG Watering R Tremblay EA Swan K Mueller CR Elliott BE: A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Oncogene 2006, 25:2773-2784. 10.1038/sj.onc.1209306 16407846
19. Hung W Elliott BE: Co-operative Effect of c-Src Tyrosine Kinase and Stat3 in Activation of Hepatocyte Growth Factor Expression in Mammary Carcinoma Cells. J Biol Chem 2001, 276:12395-12403. 10.1074/ jbc.M010715200 11278729
20. Muthuswamy S Siegel P Dankort D Webster M Muller W: Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol 1994, 14:735-743. 358422 7903421
21. Muthuswamy S Muller W: Activation of the Src family of tyrosine kinases in mammary tumorigenesis. Advanced Cancer Research 1994, 64:111-123.
22. Vadlamudi R Sahin A Adam L Wang R Kumar R: Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215. FEBS Letters 2003, 543:76-80. 10.1016/S0014-5793(03)00404-6 12753909
23. Schmitz K Grabellus F Callies R Otterbach F Wohlschlaeger J Levkau B Kimmig R Schmid K Baba H: High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Research 2005, 7:R194-R203. 1064131 15743500 10.1186/bcr977
24. Hsieh F Cheng G Lin J: Evaluation of potential Stat3-regulated genes in human breast cancer. Biochemical and Biophysical Research Communications 2005, 335:292-299. 10.1016/j.bbrc.2005.07.075
25. Yeh Y Ou-Yang F Chen I Yang S Wang Y Chuang H Su J Hou M Yuan S: Stat3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma. International Journal of Cancer 2006, 118:2943-2947. 10.1002/ijc.21771